Status:
UNKNOWN
Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
In the present study will be compared Carbetocin with ergometrin in the prevention of postpartum haemorrhage (PPH) in parturients that are undergoing caesarean section and are not presenting risk fact...
Detailed Description
In the particular study the investigators will compare the effect of Carbetocin and ergometrin in the prevention of postpartum haemorrhage. It is a prospective comparative single blind randomized stud...
Eligibility Criteria
Inclusion
- Female gender Gestating Between 18-40 years No co-morbidity
Exclusion
- Exclusion Criteria
- Under age parturients
- Parturients \>40 years of age
- Multiple pregnancies
- Parturients with abnormal placental adhesion
- Parturients with two or more caesarian sections in the past
- Parturients with haematological diseases
- Parturients that receive anticoagulation therapy for a concomitant disease
- Parturients with severe co-morbidity
- Refusal to sign the consent form
- Caesarian section under general anaesthesia
Key Trial Info
Start Date :
April 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04300452
Start Date
April 5 2018
End Date
September 30 2020
Last Update
March 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital "Elena Venizelou"
Athens, Attica, Greece, 11525